We are specialized in the importation, distribution, and commercialization of our proprietary brands, backed by an expert regulatory team executing sanitary registrations across Latam. Our supply channels serve both the Institutional Sector and the Private Commercial Marketplace directly and through long-standing distribution partnerships.
To be the leading pharmaceutical company, recognized for operations characterized by quality, reliability, and high competitiveness.
To provide customers with pharmaceutical products of the highest quality, in order to effectively meet market needs and achieve a positive impact on the health and well-being of the community.
"We promise top quality products delivered by utmost care, safety and wellbeing."
Connecting world-class manufacturing with Latin America's healthcare systems, ensuring rigorous regulatory compliance, accessible pricing, and dependable supply for public institutions and communities.
Manufactured under the highest international cGMP quality standards, our pharmaceutical portfolio complies with stringent global pharmacopeia and regulatory requirements across the Americas and Europe.
From internationally accredited manufacturing plants to advanced climate-controlled warehousing, we ensure every medicine meets the highest standards of safety, efficacy, and compliance.
Partnered with premier plants accredited by US FDA, EMA-EU, UK-MHRA, and COFEPRIS, guaranteeing strict cGMP compliance for oral solids and critical care injectables.
Dedicated regulatory affairs and pharmacovigilance teams ensuring swift health registrations, bioequivalence compliance, and continuous safety monitoring across 10+ countries.
Strategic distribution centers in Mexico, Colombia and Ecuador with temperature-monitored storage and secure supply chain management for institutional public and private markets.
Serving Institutional & Private Markets across 10 Latam Countries
Get in touch with our commercial and operations teams in Mexico and Colombia for institutional procurement, tenders, and pharmaceutical supply across Latin America.
Commercial & Institutional Desk
Commercial Desk
Meet the executive leadership, regulatory experts, and operations specialists driving Delsha Lifescience and Setaa Pharma across Latin America.
Driven by a vision to make accessible healthcare available to mass populations across Latin America, Kanchan founded Setaa Pharma in 2015. With over 22 years of dual-market experience spanning India and LATAM, she previously helped establish several prominent Indian pharmaceutical giants in the region. After launching Setaa Pharma in Colombia, she expanded operations into Ecuador and Central America, and later scaled into Mexico in 2022 under the corporate banner of Delsha Lifescience.
Bringing deep, hands-on expertise in the Latin American pharmaceutical landscape, Pawan joined the group in 2022 to structure and expand its regional portfolio. Armed with a sharp focus on strategic branding and market positioning for both Setaa and Delsha, he draws on a leadership track record stretching from 2005 to 2022—having held various high-impact roles from Country Manager to Regional Business Head with multiple leading pharma firms.